STAT

STAT+: Pharmalittle: Online prescribing prompts scrutiny and concern; FDA is pushed to approve OTC birth control pills

Drug companies say online prescribing will improve patient access, but health policy experts worry gaps in regulatory oversight leave patients vulnerable.
Source: Alex Hogan/STAT

Top of the morning to you. Gray skies are hovering once again over the Pharmalot campus right now, but our spirits

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About The Purdue Bankruptcy Ruling, A Merck Rejection, And More
In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
STAT1 min read
STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Alzheimer’s Drug, An EU Contract For Bird Flu Vaccine, And More
Advisers to the FDA voted unanimously to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly.

Related Books & Audiobooks